Viscus Biologics was founded in 2012 to help companies solve complex challenges ranging from ideation to high volume production. We are specialists in natural polymer and extracellular matrix materials, with the ability to develop and manufacture highly-specialized components, devices, and products needed to restore tissue to a healthy, functioning, and durable state. A LIFE SCIENCE PARTNER Whatever biomaterial needs you may have, companies can depend on Viscus Biologics for succesful product realization, quality manufacturing and timely distribution. With over ten years of operating excellence, we are thoroughly experienced with established procedures, policies, and a quality system to support product realization. PROVEN PROCESS The established D4 (Define, Discover, Develop, Deliver) process ensures that components, devices, and products are successfully realized and optimized for high performance. ROBUST SUPPLY CHAIN Our robust and domestic centered supply chain and partner network ensures consistency, cost-containment, availability, and timely delivery of components, devices, and products.
Looking for a particular Viscus Biologics LLC employee's phone or email?
The Viscus Biologics LLC annual revenue was $1 million in 2026.
Peter Gingras is the President and CEO of Viscus Biologics LLC.
12 people are employed at Viscus Biologics LLC.
Viscus Biologics LLC is based in Cleveland, Ohio.
The NAICS codes for Viscus Biologics LLC are [3254, 32, 325, 32541].
The SIC codes for Viscus Biologics LLC are [283, 28].